Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture

Introduction  species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2023-04, Vol.15 (4), p.e38183-e38183
1. Verfasser: Dalyan Cilo, Burcu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e38183
container_issue 4
container_start_page e38183
container_title Curēus (Palo Alto, CA)
container_volume 15
creator Dalyan Cilo, Burcu
description Introduction  species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training & Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236 strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the   strains, 131 were  (55.5%), 40 were  SC (16.9%), 21 were  (8.9%), 19 were   SC (8.1%), eight were  (3.4%), seven were  (3.0%), six were  (2.6%), two were  (0.8%) and two were  (0.8%). Amphotericin B resistance was not detected in   strains. Micafungin susceptibility was 98.3%, and four   SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from  strains which intrinsically resistant to fluconazole, three   (7.5%), one  SC (5.3%) strain were resistant (R) to fluconazole, and one   (12.5%) strain was wild-type (WT). Voriconazole susceptibility of   strains was 98.6%. Two   SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.  SC strains showed decreased susceptibility to fluconazole, whereas   strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.
doi_str_mv 10.7759/cureus.38183
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10224711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2821276938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</originalsourceid><addsrcrecordid>eNpdkc1LxDAQxYMoKurNswS8eHDXSdJ2uifR9RMWPKjnkLapRrLNmg_B_96sq6IehhmY3zzm8QjZZzBGLCcnbfI6hbGoWS3WyDZnVT3Kc7H-a94ieyG8AAAD5ICwSbYE8pKXE9wm7f1Ct0YHemFC9KZJ0biBqqGjZ0M0fRqelKX3KbR6EU1jrIlL2PV0mhnTKfp9fxucVVF39Mq7OT23znV0mmzMD-6SjV7ZoPe--g55vLp8mN6MZnfXt9Oz2agVAHHEOkRVFlDV0GgEhkzzstNCVKAF9gyLqkeRDWDVVhqEKEuWq4GyYCg6IXbI6Up3kZq57lo9RK-sXHgzV_5dOmXk381gnuWTe5MMOC-Qsaxw9KXg3WvSIcq5ydatVYN2KUhec5gg8Ipn9PAf-uKSH7K_JcU4VhNRZ-p4RbXeheB1__MNA7lMUK4SlJ8JZvzgt4Mf-Dsv8QEk9pc5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821276938</pqid></control><display><type>article</type><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Dalyan Cilo, Burcu</creator><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><description>Introduction  species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training &amp; Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236 strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the   strains, 131 were  (55.5%), 40 were  SC (16.9%), 21 were  (8.9%), 19 were   SC (8.1%), eight were  (3.4%), seven were  (3.0%), six were  (2.6%), two were  (0.8%) and two were  (0.8%). Amphotericin B resistance was not detected in   strains. Micafungin susceptibility was 98.3%, and four   SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from  strains which intrinsically resistant to fluconazole, three   (7.5%), one  SC (5.3%) strain were resistant (R) to fluconazole, and one   (12.5%) strain was wild-type (WT). Voriconazole susceptibility of   strains was 98.6%. Two   SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.  SC strains showed decreased susceptibility to fluconazole, whereas   strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.38183</identifier><identifier>PMID: 37252597</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antifungal agents ; Automation ; Epidemiology ; Fungal infections ; Infectious Disease ; Laboratories</subject><ispartof>Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38183-e38183</ispartof><rights>Copyright © 2023, Dalyan Cilo et al.</rights><rights>Copyright © 2023, Dalyan Cilo et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Dalyan Cilo et al. 2023 Dalyan Cilo et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224711/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224711/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37252597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Introduction  species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training &amp; Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236 strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the   strains, 131 were  (55.5%), 40 were  SC (16.9%), 21 were  (8.9%), 19 were   SC (8.1%), eight were  (3.4%), seven were  (3.0%), six were  (2.6%), two were  (0.8%) and two were  (0.8%). Amphotericin B resistance was not detected in   strains. Micafungin susceptibility was 98.3%, and four   SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from  strains which intrinsically resistant to fluconazole, three   (7.5%), one  SC (5.3%) strain were resistant (R) to fluconazole, and one   (12.5%) strain was wild-type (WT). Voriconazole susceptibility of   strains was 98.6%. Two   SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.  SC strains showed decreased susceptibility to fluconazole, whereas   strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</description><subject>Antifungal agents</subject><subject>Automation</subject><subject>Epidemiology</subject><subject>Fungal infections</subject><subject>Infectious Disease</subject><subject>Laboratories</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkc1LxDAQxYMoKurNswS8eHDXSdJ2uifR9RMWPKjnkLapRrLNmg_B_96sq6IehhmY3zzm8QjZZzBGLCcnbfI6hbGoWS3WyDZnVT3Kc7H-a94ieyG8AAAD5ICwSbYE8pKXE9wm7f1Ct0YHemFC9KZJ0biBqqGjZ0M0fRqelKX3KbR6EU1jrIlL2PV0mhnTKfp9fxucVVF39Mq7OT23znV0mmzMD-6SjV7ZoPe--g55vLp8mN6MZnfXt9Oz2agVAHHEOkRVFlDV0GgEhkzzstNCVKAF9gyLqkeRDWDVVhqEKEuWq4GyYCg6IXbI6Up3kZq57lo9RK-sXHgzV_5dOmXk381gnuWTe5MMOC-Qsaxw9KXg3WvSIcq5ydatVYN2KUhec5gg8Ipn9PAf-uKSH7K_JcU4VhNRZ-p4RbXeheB1__MNA7lMUK4SlJ8JZvzgt4Mf-Dsv8QEk9pc5</recordid><startdate>20230427</startdate><enddate>20230427</enddate><creator>Dalyan Cilo, Burcu</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230427</creationdate><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><author>Dalyan Cilo, Burcu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antifungal agents</topic><topic>Automation</topic><topic>Epidemiology</topic><topic>Fungal infections</topic><topic>Infectious Disease</topic><topic>Laboratories</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dalyan Cilo, Burcu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-04-27</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e38183</spage><epage>e38183</epage><pages>e38183-e38183</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Introduction  species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training &amp; Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236 strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the   strains, 131 were  (55.5%), 40 were  SC (16.9%), 21 were  (8.9%), 19 were   SC (8.1%), eight were  (3.4%), seven were  (3.0%), six were  (2.6%), two were  (0.8%) and two were  (0.8%). Amphotericin B resistance was not detected in   strains. Micafungin susceptibility was 98.3%, and four   SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from  strains which intrinsically resistant to fluconazole, three   (7.5%), one  SC (5.3%) strain were resistant (R) to fluconazole, and one   (12.5%) strain was wild-type (WT). Voriconazole susceptibility of   strains was 98.6%. Two   SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.  SC strains showed decreased susceptibility to fluconazole, whereas   strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37252597</pmid><doi>10.7759/cureus.38183</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38183-e38183
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10224711
source PubMed Central; PubMed Central Open Access
subjects Antifungal agents
Automation
Epidemiology
Fungal infections
Infectious Disease
Laboratories
title Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A38%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Species%20Distribution%20and%20Antifungal%20Susceptibilities%20of%20Candida%20Species%20Isolated%20From%20Blood%20Culture&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Dalyan%20Cilo,%20Burcu&rft.date=2023-04-27&rft.volume=15&rft.issue=4&rft.spage=e38183&rft.epage=e38183&rft.pages=e38183-e38183&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.38183&rft_dat=%3Cproquest_pubme%3E2821276938%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2821276938&rft_id=info:pmid/37252597&rfr_iscdi=true